A Cost-Effectiveness Assessment of Dalteparin as a Prophylactic and Therapeutic Agent for the Management of Thromboembolic Venous Disease (VTE) in Mexican Adult Patients after Total Hip Replacement
Arreola-Ornelas H., Rosado-Buzzo A., García Mollinedo L., Dorantes-Aguilar J., Muciño-Ortega E., Mould-Quevedo J.F., Dávila-Loaiza G.
